P. Santos-Moreno

ORCID: 0000-0001-7802-0317
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Biosimilars and Bioanalytical Methods
  • Chronic Lymphocytic Leukemia Research
  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Chronic Disease Management Strategies
  • Spondyloarthritis Studies and Treatments
  • Health and Medical Education
  • Lymphoma Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Viral Infections and Immunology Research
  • Medication Adherence and Compliance
  • COVID-19 Clinical Research Studies
  • Systemic Sclerosis and Related Diseases
  • Urticaria and Related Conditions
  • Hepatitis C virus research
  • Medical and Biological Sciences
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Tuberculosis Research and Epidemiology
  • Telemedicine and Telehealth Implementation
  • Pharmaceutical studies and practices
  • Autoimmune Bullous Skin Diseases
  • Pharmaceutical Economics and Policy
  • Vasculitis and related conditions

Universidad Nacional de Colombia
2024

Fundación Universitaria de Ciencias de la Salud
2024

Center for Rheumatology
2013-2023

Fundacion Instituto de Reumatologia Fernando Chalem
2014-2023

University of Bern
2021

Palmetto Hematology Oncology
2016-2017

Creative Commons
2016

Sociedad Española de Reumatología
2015

Instituto Nacional de Rehabilitación
2015

Military University Nueva Granada
2013

Purpose: To determine the value of lung ultrasound (LUS) compared to high-resolution computed tomography (HRCT) in early diagnosis interstitial disease (ILD) patients with rheumatoid arthritis (RA). Patients and Methods: An observational prospective study was performed. Were included respiratory symptoms or/and, crackles auscultation during medical consultation. All underwent chest X-rays, LUS, HRCT,and function tests. Results: A total 192 RA were included. Mean duration 16.8 ± 11.1 years....

10.2147/oarrr.s441720 article EN cc-by-nc Open Access Rheumatology Research and Reviews 2024-01-01

Rheumatoid arthritis (RA) is a chronic disease of autoimmune origin and occurs most frequently between the ages 40 60. RA associated with comorbidities such as sexual disorders sleep that affect patient's quality life.

10.46856/grp.10.et198 article EN cc-by-nc Global Rheumatology 2025-03-07

La artritis reumatoide (AR) es una enfermedad crónica de origen autoinmune y se presenta con mayor frecuencia entre los 40 60 años. AR asocia a comorbilidades como trastornos sexuales del sueño que afectan la calidad vida paciente.

10.46856/grp.10.e198 article ES cc-by-nc Global Rheumatology 2025-03-07

A artrite reumatoide (AR) é uma doença crônica de origem autoimune e ocorre com maior frequência entre 40 60 anos. AR está associada a comorbidades como distúrbios sexuais do sono que afetam qualidade vida paciente.

10.46856/grp.10.ept198 article PT cc-by-nc Global Rheumatology 2025-03-07

Experimental models suggest the use of different therapy protocols in rheumatoid arthritis (RA) as modulators on periodontal condition. This study evaluated effects conventional drug treatment and anti-TNF patients with RA microbiological condition, establishing association markers infection indexes rheumatic activity.One hundred seventy nine individuals were (62 anti-TNF-. 115 only DMARDs). The evaluation included plaque gingival indexes, bleeding probing (BOP), clinical attachment loss...

10.2174/1573397113666170407161520 article EN Current Rheumatology Reviews 2017-04-13

We determined whether rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) can predict remission or severe disability in arthritis (RA) patients treated with anti-tumor necrosis (TNF) alpha drugs.We performed a cohort study based on the clinical data from referral center for treatment of RA Bogotá, Colombia, were included aged ≥18 years diagnosis an active disease whom scheme was begun anti-TNF medication, minimum follow-up time 12 months. Disease activity Rheumatoid...

10.1097/md.0000000000014181 article EN cc-by-nc Medicine 2019-01-31

Objective A consensus meeting of representatives 16 Latin American and Caribbean countries the REAL-PANLAR group met in city Bogota to provide recommendations for improving quality care patients with rheumatoid arthritis (RA) America, defining a minimum standards concept center excellence RA. Methods Twenty-two rheumatologists from special interest RA participated meeting. Two Colombian 2 health advisors were also invited RAND-modified Delphi procedure 5 steps was applied define categories...

10.1097/rhu.0000000000000247 article EN cc-by-nc-nd JCR Journal of Clinical Rheumatology 2015-05-22

Abstract Background Globally, osteoarthritis (OA) is the third condition associated with disability. There still poor treatment in OA but science holds key to finding better treatments and a cure. It essential learn what’s important patients from them implement most effective management. The Patients Task Force, conducted Global Patient Perception Survey (GOAPPS)-the first global survey made by analize quality of life (QoL) & patient perceptions care. goal was collect data on patients’...

10.1186/s12891-020-03741-0 article EN cc-by BMC Musculoskeletal Disorders 2020-11-07

This study aimed to compare the clinical response at 36 months and evaluate adverse events in a cohort of patients with rheumatoid arthritis treated etanercept, infliximab, or adalimumab.An observational retrospective was performed. Patients older than 18 years active arthritis, for which physician had initiated treatment scheme adalimumab, were included study. The follow-up conducted through least trimestral evaluations during course months. Outcomes evaluated Disease Activity Score 28,...

10.1097/rhu.0000000000000358 article EN JCR Journal of Clinical Rheumatology 2016-02-17

Biologics have improved the treatment of rheumatic diseases, resulting in better outcomes. However, their high cost limits access for many patients both North America and Latin America. Following patent expiration biologicals, availability biosimilars, which typically are less expensive due to lower development costs, provides additional options with diseases. The biosimilars American countries is evolving, differing regulations clinical indications. objective study was present consensus...

10.1007/s10067-019-04496-3 article EN cc-by Clinical Rheumatology 2019-03-27

<h3>Background:</h3> In Rheumatoid Arthritis (RA), the use of bDMARD (biological) medications is considered among treatment options as part control disease activity. Pharmacovigilance programs deals with detection, evaluation and understanding adverse events medications. recent years there have been reports about increased risk events, especially cardiovascular thrombotic JAK inhibitors. <h3>Objectives:</h3> To make a comparison drug reactions (DAR) (DAE) between inhibitors anti-TNFs in...

10.1136/annrheumdis-2024-eular.2563 article EN Annals of the Rheumatic Diseases 2024-06-01

To assess the frequency of polyautoimmunity (PolyA) in a cohort Colombian patients with systemic lupus erythematosus (SLE) and to identify associated factors.This is an analytical cross-sectional study specialized center., comprehensive review medical records SLE was performed from 2015 2020 order obtain demographic, clinical data, laboratory, treatment information. Associations between PolyA, characteristics disease were explored.A total 463 included analysis. The average age 47.3 ± 15...

10.1016/j.jtauto.2022.100187 article EN cc-by-nc-nd Journal of Translational Autoimmunity 2023-01-01

The risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) is 1.5-2 times higher than the general population. fundamental factor for CVD age, related to alterations at arterial level. aim study was compare vascular age (VA) RA under a strict treat-to-target (T2T) strategy Osteoarthritis (OA) without follow up and assess influence inflammaging (chronic, sterile, low-grade inflammation aging) metabolic markers on VA.This an analytical cross-sectional study. Patients...

10.3389/fcvm.2022.894577 article EN cc-by Frontiers in Cardiovascular Medicine 2022-07-05

Rheumatoid arthritis (RA) is a chronic and progressive pathology, present in between 0.5% 1% of adults. Sexual disorders (SDs) occur 31% 70% all patients with RA.To establish the associated risk factors prevalence SDs group RA.An analytical cross-sectional study was performed, evaluated Diagnostic Statistical Manual Mental Disorders-V tool. The related activity disease were explored. A multivariate logistic regression analysis conducted.The 29.6%. There an association presence gender (women;...

10.1016/j.esxm.2020.04.003 article EN cc-by-nc-nd Sexual Medicine 2020-05-15

The First PANLAR Rheumatology Review Course was held in Barranquilla, Colombia, April 2015. Researchers, rheumatologists, epidemiologists, and a variety of allied professionals patients attended the meeting. scientific program included plenary sessions symposia delivered by renowned experts field, followed an interactive forum discussion during 2 days.A broad spectrum topics discussed, reflecting current challenges opportunities for diagnosis treatment rheumatoid arthritis (RA) Latin...

10.1097/rhu.0000000000000318 article EN JCR Journal of Clinical Rheumatology 2015-10-29

By 2015, the World Health Organization reported that 1% of world population suffered from rheumatoid arthritis (RA) and in Latin America (LA) between 0.5% 1%. Previously, May 2014, a consensus meeting was held Barranquilla, Colombia, where Project for Implementation Accreditation Centers Excellence (CoE) RA LA established, which then became an official special group Pan American League Associations Rheumatology (PANLAR).The aim this study to define methodological approach accreditation...

10.1097/rhu.0000000000000773 article EN JCR Journal of Clinical Rheumatology 2018-03-29
Coming Soon ...